But Hims & Hers' shares fell in after-hours trading as second-quarter projections fell short of analysts' expectations. The ...

Telehealth company Hims & Hers reported first-quarter results late Monday that beat Wall Street estimates. But parts of the ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy ...

But the many millions of people who tune into the Super Bowl won't learn that from this ad." For its part, Hims & Hers maintains that the 'Sick of the System' ad – its first for a Super Bowl ...

Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...

(Hims & Hers Health) Telehealth provider Hims & Hers Health is defending its Super Bowl ad, which is styled as a political manifesto against weight-loss treatments priced “for profits ...

GMA” caught up with the newly-crowned Super Bowl MVP at Walt Disney World after the Philadelphia Eagles’ big win against the Kansas City Chiefs. The tele-health company Hims & Hers Health is ...

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results tomorrow after the bell. Here’s what investors should know. Hims & Hers Health beat analysts’ revenue expectations ...

In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against other Friday's top performers. The stock market ended the trading week on a strong note ...

The companies, which have at times had an adversarial relationship, also said they would develop a roadmap to continue their ...

Hims & Hers Health (HIMS ... driving 35% of conversions through relatable content Brand Campaigns: Super Bowl ads and billboards normalize conversations about sensitive health issues Algorithmic ...